ECONOMIC EVALUATION OF SEQUENCING STRATEGIES IN THE TREATMENT OF PSORIATIC ARTHRITIS IN THE UNITED STATES

被引：0
|
作者：
Tencer, T. [1 ]
Clancy, Z. [2 ]
Cawston, H. [3 ]
Damera, V [4 ]
Berardi, A. [4 ]
Cure, S. [4 ]
机构：
[1] Celgene Corp, Summit, NJ USA
[2] Celgene Corp, Warren, NJ USA
[3] OptumInsight, Nanterre, France
[4] OptumInsight, Uxbridge, Middx, England
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.276
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS31
引用
收藏
页码：A46 / A46
页数：1
相关论文
共 50 条
  • [31] Burden of Herpes Zoster Among Patients with Psoriatic Arthritis in the United States
    Singer, David
    Thompson-Leduc, Philippe
    Ma, Siyu
    Gupta, Deepshekhar
    Cheng, Wendy Y.
    Sendhil, Selvam R.
    Sundar, Manasvi
    Hagopian, Ella
    Stempniewicz, Nikita
    Duh, Mei Sheng
    Poston, Sara
    PSORIASIS-TARGETS AND THERAPY, 2024, 14 : 63 - 78
  • [32] Economic evaluation of ezetimibe treatment in combination with statin therapy in the United States
    Davies, Glenn M.
    Vyas, Ami
    Baxter, Carl A.
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (07) : 723 - 731
  • [33] Economic evaluation of apremilast in the treatment of moderate to severe psoriasis in the United States
    Tencer, Tom
    Clancy, Zoe
    Damera, Vidya
    Zhang, Frank
    Cure, Sandrine
    Feldman, Steven
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB97 - AB97
  • [34] Biological therapy in the treatment of psoriatic arthritis: economic and epidemiological considerations
    Ribeiro da Silva, Michael Ruberson
    Ribeiro dos Santos, Jessica Barreto
    Almeida, Alessandra Maciel
    Guerra Junior, Augusto Afonso
    Teodoro, Juliana Alvares
    Acurcio, Francisco de Assis
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2019, 15 (08) : 879 - 887
  • [35] The economic implications of TNF-α inhibitors in the treatment of Psoriatic Arthritis
    Bansback, N
    Barkham, N
    Ara, R
    Fraser, A
    Emery, P
    Conway, P
    Reynolds, A
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S509 - S510
  • [36] Therapy strategies in psoriatic arthritis
    Coates, L. C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (05) : S70 - S72
  • [37] Economic burden of psoriatic arthritis
    Ackermann, Christoph
    Kavanaugh, Arthur
    PHARMACOECONOMICS, 2008, 26 (02) : 121 - 129
  • [38] Economic Burden of Psoriatic Arthritis
    Christoph Ackermann
    Arthur Kavanaugh
    PharmacoEconomics, 2008, 26 : 121 - 129
  • [39] PATIENT ELIGIBILITY AND USE OF BIOLOGICS IN RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS IN THE UNITED STATES
    Narayanan, S.
    Baskett, A.
    Lu, Y.
    Hutchings, R.
    VALUE IN HEALTH, 2013, 16 (07) : A572 - A572
  • [40] An Economic Evaluation of Tofacitinib (Xeljanz) Treatment in Rheumatoid Arthritis: Modeling the Cost of Treatment Strategies in the US
    Claxton, Lindsay
    Taylor, Matthew
    Jenks, Michelle
    Wallenstein, Gene
    Mendelsohn, Alan
    Bourret, Jeffrey
    Singh, Amitabh
    Gerber, Robert
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
12345